Alaunos Therapeutics | ZIOP - Pre Tax Profit


Alaunos Therapeutics reported $-7.84M in Pre-Tax Profit for its fiscal quarter ending in December of 2023.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Baxter International USD -756M 877M Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Bioline Rx USD -2.59M 352K Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Celltrion KRW 11.84B 1.34B Mar/2026
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 9.63B 1.09B Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Incyte USD 343.6M 46.34M Mar/2026
Intrexon USD -60.48M 27.09M Jun/2024
Ionis Pharmaceuticals USD -93M 135M Mar/2026
J&J USD 8.66B 839M Jun/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Merck USD 3.42B 3.32B Dec/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Novartis USD 3.84B 802M Mar/2026
Organigram Holdings CAD -921K 40.8M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Pharma Mar EUR 1.6M 38.6M Mar/2026
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Qiagen NV USD 109.17M 25.56M Dec/2025
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sartorius EUR 157.8M 76.1M Mar/2026
TG Therapeutics USD 20.36M 24.73M Mar/2026
Tilray USD -39.96M 39.19M Sep/2025
Verastem USD -32.92M 944K Dec/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026